Patents by Inventor Anand Sistla

Anand Sistla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Salts and polymorphs of a VEGF-R inhibitor
    Patent number: 7928226
    Abstract: The invention relates to salts and free base forms of N,2-dimethyl-6-[7-(2-morpholinoethoxy)quinolin-4-yloxy]benzofuran-3-carboxamide. The invention further relates to pharmaceutical compositions of these salts and free base forms and methods of treating disorders such as cancer using such compositions.
    Type: Grant
    Filed: July 27, 2006
    Date of Patent: April 19, 2011
    Assignee: Agouron Pharmaceuticals Inc.
    Inventors: Yi Li, Jia Liu, Anand Sistla, Bruce Joseph Elder, Yufeng Hong, Paul Kenneth Isbester, Grant Jackson Palmer, Jonathon Stuart Salsbury, Luckner Gerard Ulysse
  • SALTS AND POLYMORPHS OF A VEGF-R INHIBITOR
    Publication number: 20090048254
    Abstract: The invention relates to salts and free base forms of N,2-dimethyl-6-[7-(2-morpholinoethoxy)quinolin-4-yloxy]benzofuran-3-carboxamide. The invention further relates to pharmaceutical compositions of these salts and free base forms and methods of treating disorders such as cancer using such compositions.
    Type: Application
    Filed: July 27, 2006
    Publication date: February 19, 2009
    Applicant: PFIZER INC.
    Inventors: Yi Li, Jia Liu, Anand Sistla, Bruce Joseph Elder, Yufeng Hong, Paul Kenneth Isbester, Grant Jackson Palmer, Jonathon Stuart Salsbury, Luckner Gerard Ulysse
  • Pharmaceutical formulations comprising indolinone derivatives
    Patent number: 7109185
    Abstract: The present invention is directed to formulations comprising 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives that modulate the activity of protein kinases (“PKs”). Methods of treating diseases related to abnormal PK activity utilizing the formulations comprising these compounds and methods of making these formulations are also disclosed.
    Type: Grant
    Filed: November 21, 2002
    Date of Patent: September 19, 2006
    Assignee: Sugen, Inc.
    Inventors: Ping Gao, Anand Sistla, Narmada Shenoy
  • Pharmaceutical formulations comprising indolinone derivatives
    Publication number: 20030176399
    Abstract: The present invention is directed to formulations comprising 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives that modulate the activity of protein kinases (“PKs”). Methods of treating diseases related to abnormal PK activity utilizing the formulations comprising these compounds and methods of making these formulations are also disclosed.
    Type: Application
    Filed: November 21, 2002
    Publication date: September 18, 2003
    Applicant: SUGEN INCORPORATED
    Inventors: Ping Gao, Anand Sistla, Narmada Shenoy